Shaping the future of cancer immunotherapies by translating compelling science into patient benefit.

SOTIO Biotech | 8,996 followers on LinkedIn. Shaping the future of cancer immunotherapies by translating compelling science into patient benefit. | SOTIO Biotech is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIO’s robust clinical pipeline includes a next-generation PD-1-inhibiting cytokine, a proprietary technology designed to improve on the efficacy of CAR T therapies and a new generation of potent and stable antibody-drug conjugates (ADCs). SOTIO is a member of the PPF Group.

Additional jobs info: Regulatory Affairs Specialist (9,102 open jobs). PHD (111,034 open jobs). Chemist (41,396 open jobs)